• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recalcitrant psoriasis responding to new bilogic drug: ustekinumab.

作者信息

Husein-ElAhmed Husein, Molina-Leyva Alejandro, Garrido-TorresPuchol Valeriano, Ruiz-Carrascosa Jose

机构信息

Dr. Husein Husein-ElAhmed, Dermatology, Infanta Margarita Hospital,, Avda Gongora s/n, Cordoba, Cabra, 14940, Spain,

出版信息

Ann Saudi Med. 2013 Nov-Dec;33(6):632-3. doi: 10.5144/0256-4947.2013.632.

DOI:10.5144/0256-4947.2013.632
PMID:24413873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6074921/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1c/6074921/f3500c86c062/asm-6-632f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1c/6074921/954ab74834b5/asm-6-632f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1c/6074921/f3500c86c062/asm-6-632f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1c/6074921/954ab74834b5/asm-6-632f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d1c/6074921/f3500c86c062/asm-6-632f2.jpg

相似文献

1
Recalcitrant psoriasis responding to new bilogic drug: ustekinumab.对新型生物制剂优特克单抗有反应的顽固性银屑病
Ann Saudi Med. 2013 Nov-Dec;33(6):632-3. doi: 10.5144/0256-4947.2013.632.
2
Resident Rounds. Part III A. Serendipitous improvement in moderate to severe acne in psoriasis patients treated with ustekinumab: a two-case series.住院医师查房。第三部分A。使用乌司奴单抗治疗的银屑病患者中重度痤疮意外改善：两例病例系列
J Drugs Dermatol. 2013 Jun 1;12(6):710-1.
3
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.优特克单抗治疗无效后换用白细胞介素-23抑制剂：评估银屑病治疗的真实世界疗效
Am J Clin Dermatol. 2024 Jul;25(4):685-688. doi: 10.1007/s40257-024-00868-x. Epub 2024 May 27.
4
Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.乌司奴单抗治疗重度复杂性红皮病型银屑病：快速清除、安全性及持续缓解
Dermatol Ther. 2014 Sep-Oct;27(5):257-9. doi: 10.1111/dth.12131. Epub 2014 May 9.
5
Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma.用优特克单抗治疗一名患有HIV相关卡波西肉瘤的银屑病患者。
Clin Exp Dermatol. 2019 Jan;44(1):113-115. doi: 10.1111/ced.13630. Epub 2018 May 24.
6
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.司库奇尤单抗在治疗中度至重度银屑病患者中，通过两年治疗展现出持续清除皮肤症状及改善患者报告结局的疗效：CLEAR研究结果
J Am Acad Dermatol. 2019 Dec;81(6):1405-1409. doi: 10.1016/j.jaad.2019.04.045. Epub 2019 Aug 6.
7
Ustekinumab induces fast response and maintenance of very severe refractory scalp psoriasis: results in two Greek patients from the psoriasis hospital-based clinic.乌司奴单抗诱导快速应答并维持极重度难治性头皮银屑病：来自银屑病医院门诊的 2 例希腊患者的结果。
Dermatology. 2014;228(2):107-11. doi: 10.1159/000357030. Epub 2014 Feb 1.
8
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials.司库奇尤单抗应答不足的银屑病患者中布罗达umab 的疗效和安全性：两项随机 III 期试验的亚组分析。
Br J Dermatol. 2019 Feb;180(2):306-314. doi: 10.1111/bjd.17318. Epub 2018 Dec 27.
9
Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis.乌司奴单抗在一名重度银屑病血液透析患者中的良好疗效及耐受性。
Eur J Dermatol. 2014 Sep-Oct;24(5):618-9. doi: 10.1684/ejd.2014.2401.
10
Ustekinumab for the treatment of HIV psoriasis.优特克单抗用于治疗HIV相关性银屑病。
J Dermatolog Treat. 2012 Dec;23(6):398-9. doi: 10.3109/09546634.2011.579085. Epub 2011 Jul 25.

引用本文的文献

1
Discovery of Novel Biomarkers with Extended Non-Coding RNA Interactor Networks from Genetic and Protein Biomarkers.从遗传和蛋白质生物标志物中发现具有扩展非编码 RNA 相互作用网络的新型生物标志物。
Int J Mol Sci. 2024 Sep 23;25(18):10210. doi: 10.3390/ijms251810210.

本文引用的文献

1
What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010.银屑病的新进展？2009-2010 年发布的指南和系统评价分析。
Clin Exp Dermatol. 2011 Aug;36(6):585-9; quiz 588-9. doi: 10.1111/j.1365-2230.2011.04108.x. Epub 2011 Jul 1.
2
Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia.抗肿瘤坏死因子-α疗法在银屑病和B细胞慢性淋巴细胞白血病治疗中的应用
Case Rep Dermatol. 2011 Mar 7;3(1):60-3. doi: 10.1159/000324344.
3
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis.
优特克单抗：关于其治疗银屑病有效性的循证综述
Core Evid. 2010 Jul 27;5:11-22. doi: 10.2147/ce.s5994.
4
Topical treatments for chronic plaque psoriasis.慢性斑块状银屑病的局部治疗
Cochrane Database Syst Rev. 2009 Apr 15(2):CD005028. doi: 10.1002/14651858.CD005028.pub2.